Lacks v. Ultragenyx Pharmaceutical, Inc
Case Number:
1:23-cv-02171
Court:
Nature of Suit:
Judge:
Firms
Companies
- Lawyers' Committee for Civil Rights
- The Lawyers' Committee for Civil Rights Under Law
- Ultragenyx Pharmaceutical Inc.
Government Agencies
Sectors & Industries:
-
September 17, 2024
Henrietta Lacks' Family Still Seeks Justice For 'Immortal' Cells
Seven decades have passed since a doctor at a Baltimore hospital took, without permission, a sample of cells from a Black woman suffering from cervical cancer. While the durable strain of human cells known as "HeLa" has fueled a handful of lawsuits against drug companies accused of profiting from stolen genetic material, more are likely on the way.
-
May 21, 2024
Judge Shopping Row, Henrietta Lacks And SC Abortion Clock
BigLaw lawyers get deeper into sanction spat, a case over profits from harvested cancer cells, and a Texas Supreme Court decision in a Fen-Phen malpractice suit. Law360 Healthcare Authority looks at those and other developments from the week in healthcare litigation.
-
May 20, 2024
Ultragenyx Must Face Suit Over Use Of Henrietta Lacks' Cells
The family of the late Henrietta Lacks, a Black woman whose cells were harvested without her knowledge to create the first immortalized human cell line, can pursue their suit alleging Ultragenyx Pharmaceutical "made a fortune" using her stolen cells to develop gene therapy treatments, a Maryland federal judge ruled Monday.
-
August 11, 2023
Henrietta Lacks' Family Sues Ultragenyx Over Stolen Cells
The family of the late Henrietta Lacks, a Black woman whose cells were harvested without her knowledge to create the first immortalized human cell line, sued Ultragenyx in Maryland federal court Thursday, alleging the biopharmaceutical company "has made a fortune" using her stolen cells in developing gene therapy treatments.